University of Strathclyde:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:University of Strathclyde - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12333
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Strathclyde (Strathclyde) is an educational service provider that offers education, learning technologies and facilities. The university offers a wide range of undergraduate and postgraduate programs, and distance learning programs through its faculties of engineering, science, humanities and social sciences, and business school, among others. It has a portfolio of international research contracts to sustain improvements in the fields of medicine, environment, energy and physics. The university also carries out collaborative agreements with the institutions, universities and businesses. Strathclyde is headquartered in Glasgow, the UK.

University of Strathclyde – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Strathclyde, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Strathclyde, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Strathclyde, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Strathclyde, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of Strathclyde, Medical Devices Deals, 2012 to YTD 2018 9
University of Strathclyde, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
University of Strathclyde, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Mironid Raises USD6.2 Million in Series A Financing 11
Partnerships 12
MGB Biopharma Enters into Agreement with University of Strathclyde 12
Optos Enters into Co-Development Agreement with NHS, University of Kent and University of Strathclyde 13
Equity Offering 14
Mironid Spin Off from University of Strathclyde 14
University of Strathclyde – Key Competitors 15
University of Strathclyde – Key Employees 16
University of Strathclyde – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Government and Public Interest 18
Oct 30, 2018: Pharmaceutical industry worth £1.7bn to Scottish economy 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
University of Strathclyde, Pharmaceuticals & Healthcare, Key Facts 2
University of Strathclyde, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Strathclyde, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Strathclyde, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Strathclyde, Deals By Therapy Area, 2012 to YTD 2018 8
University of Strathclyde, Medical Devices Deals, 2012 to YTD 2018 9
University of Strathclyde, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Mironid Raises USD6.2 Million in Series A Financing 11
MGB Biopharma Enters into Agreement with University of Strathclyde 12
Optos Enters into Co-Development Agreement with NHS, University of Kent and University of Strathclyde 13
Mironid Spin Off from University of Strathclyde 14
University of Strathclyde, Key Competitors 15
University of Strathclyde, Key Employees 16
University of Strathclyde, Subsidiaries 17

List of Figures
University of Strathclyde, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of Strathclyde, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of Strathclyde, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of Strathclyde, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of Strathclyde, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Strathclyde, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
University of Strathclyde, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Strathclyde, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of Strathclyde, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[University of Strathclyde:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ko Yo Chemical (Group) Ltd (827):企業の財務・戦略的SWOT分析
    Ko Yo Chemical (Group) Ltd (827) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Syntimmune Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Syntimmune Inc (Syntimmune) is a clinical-stage biotechnology company that focuses to develop Fc receptor (FcRn) based antibody therapeutics for the treatment of autoimmune diseases. Its lead pipeline products includes SYNT001, an investigational humanized IgG4 monoclonal antibody that inhib …
  • Twist Bioscience Corp (TWST):製薬・医療:M&Aディール及び事業提携情報
    Summary Twist Bioscience Corp (Twist Bioscience) is a provider of synthetic DNA Tools. Its silicon-based DNA synthesis platform enables precise synthesis and sequencing process and production of synthetic DNA tools. The company offers its products which include DNA tools for gRNA cloning such as una …
  • China Gezhouba Group Co Ltd (600068):企業の財務・戦略的SWOT分析
    China Gezhouba Group Co Ltd (600068) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Exalenz Bioscience Ltd (EXEN):医療機器:M&Aディール及び事業提携情報
    Summary Exalenz Bioscience Ltd (Exalenz) carries out the development and commercialization of advanced medical systems for a range of gastrointestinal (GI) tract and liver disorders. The company harnesses its BreathID technology platform for assessment and monitoring of functional diseases. Its flag …
  • Eskom Holdings SOC Limited:企業の戦略・SWOT・財務情報
    Eskom Holdings SOC Limited - Strategy, SWOT and Corporate Finance Report Summary Eskom Holdings SOC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Zimmer Biomet Holdings Inc.:企業のM&A・事業提携・投資動向
    Zimmer Biomet Holdings Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Zimmer Biomet Holdings Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Seven Generations Energy Ltd (VII):企業の財務・戦略的SWOT分析
    Seven Generations Energy Ltd (VII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Green Dot Corporation:企業の戦略・SWOT・財務情報
    Green Dot Corporation - Strategy, SWOT and Corporate Finance Report Summary Green Dot Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Fractyl Laboratories Inc:医療機器:M&Aディール及び事業提携情報
    Summary Fractyl Laboratories Inc (Fractyl) is a clinical-stage medical technology company that develops novel devices and procedures to overcome insulin resistance and restitute metabolic health. The company developed a device-based clinical platform to change the way of treating metabolic diseases. …
  • Genetic Technologies Ltd (GTG):企業の製品パイプライン分析
    Summary Genetic Technologies Ltd (GTG) is a molecular diagnostic company that offers testing products and services to assess sporadic breast cancer risk and colorectal cancer risk assessment. It delivers the offerings by GeneType for breast cancer tests and GeneType test for colorectal cancer. GeneT …
  • Tullow Oil plc:戦略・SWOT・企業財務分析
    Tullow Oil plc - Strategy, SWOT and Corporate Finance Report Summary Tullow Oil plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Marston’s PLC:企業の戦略・SWOT・財務分析
    Marston's PLC - Strategy, SWOT and Corporate Finance Report Summary Marston's PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • DJO Global Inc:医療機器:M&Aディール及び事業提携情報
    Summary DJO Global Inc. (DJO) is a medical device company. The company engages in provision of orthopaedic devices. DIO develops, manufactures and distributors orthopaedic devices for musculoskeletal health, vascular health and pain management solutions. The company products include rigid and soft o …
  • Hindustan ZInc Ltd:企業の戦略・SWOT・財務情報
    Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report Summary Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • GE Aviation:企業の戦略・SWOT・財務情報
    GE Aviation - Strategy, SWOT and Corporate Finance Report Summary GE Aviation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • The Avascent Group:企業の戦略・SWOT・財務情報
    The Avascent Group - Strategy, SWOT and Corporate Finance Report Summary The Avascent Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Analog Devices, Inc.:企業の戦略・SWOT・財務情報
    Analog Devices, Inc. - Strategy, SWOT and Corporate Finance Report Summary Analog Devices, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Schott AG:企業の戦略的SWOT分析
    Schott AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Luxottica Group S.p.A.:企業の戦略・SWOT・財務情報
    Luxottica Group S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Luxottica Group S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆